Graham H. Allcock

Use of the endothelin antagonists BQ‐123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF

Timothy D. Warner, Graham H. Allcock, Roger Corder et al. · British Journal of Pharmacology · 1993 · 176 citations · Full text

Life Sciences, Pharmacology, Physiology +16

Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties

Stephen J. Getting, Graham H. Allcock, Roderick J. Flower et al. · Journal of Leukocyte Biology · 2001 · 85 citations

Life Sciences, Immunology, Pharmacology +17

Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1

Graham H. Allcock, Mario Allegra, R.J. Flower et al. · Clinical & Experimental Immunology · 2001 · 65 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Comparative Studies with the Endothelin Receptor Antagonists BQ-123 and PD 142893 Indicate At Least Three Endothelin Receptors

Timothy D. Warner, Graham H. Allcock, Emma J. Mickley et al. · Journal of Cardiovascular Pharmacology · 1993 · 64 citations

Medicine, Pharmacology, Physiology +10

Reversal of established responses to endothelin‐1 <i>in vivo</i> and <i>in vitro</i> by the endothelin receptor antagonists, BQ‐123 and PD 145065

Timothy D. Warner, Graham H. Allcock, John R. Vane · British Journal of Pharmacology · 1994 · 63 citations · Full text

Medicine, Pharmacology, Physiology +14